Adage Capital Partners Gp, L.L.C. Exact Sciences Corp Transaction History

Adage Capital Partners Gp, L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$56.27 - $73.77 $6.19 Million - $8.11 Million	-110,000 Reduced 85.8%	18,200 $1.26 Million
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $401,608 - $514,896	-6,800 Reduced 5.04%	128,200 $9.48 Million
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $8.9 Million - $13.4 Million	135,000 New	135,000 $9.21 Million
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $4.48 Million - $5.9 Million	-50,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$61.98 - $96.5 $3.78 Million - $5.89 Million	-61,000 Reduced 54.95%	50,000 $4.33 Million
Q4 2018 Feb 14, 2019	BUY	$56.04 - $82.66 $616,440 - $909,260	11,000 Added 11.0%	111,000 $7 Million
Q3 2018 Nov 14, 2018	BUY	$48.29 - $80.6 $4.83 Million - $8.06 Million	100,000 New	100,000 $7.89 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.